Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.52 |
| ▸ | HRH1 | P35367 | 2/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304130 | 1.00 | HTR2A (0.52) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL10207211 | 1.00 | HTR2A (0.52) | HTR2AHRH1PGRADRA2AADRA2B | |
| Hydrochloric Acid SCHEMBL4356665 | 0.97 | HTR2A (0.50) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL9764180 | 0.89 | HTR2A (0.44) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL3200413 | 0.85 | HTR2A (0.41) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL10064563 | 0.85 | ADRA2A (0.41) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL7904494 | 0.85 | HTR2A (0.41) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL17636225 | 0.85 | ADRA2A (0.41) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL27277859 | 0.84 | HTR2A (0.40) | HTR2AHRH1PGRADRA2AADRA2B | |
| SCHEMBL10207192 | 0.82 | PGR (0.39) | HTR2AHRH1PGRADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 515 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118125936-A | N-acyl ethanolamide derivative, preparation method and application thereof | 南京清普生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-116469621-B | Production process of ultrathin transposed conductor | 沈阳宏远电磁线股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116469621-A | Production process of ultrathin transposed conductor | 沈阳宏远电磁线股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| EP-3335720-A1 | C-DI-GMP BINDING PEPTIDES | Universität Basel (CH) | 2018-06-20 | — | — | EP | claimed |
| EP-1098871-B1 | alpha-AMINO ACID PHENYL ESTER DERIVATIVES | AKZO NOBEL NV (NL) | 2003-07-09 | — | — | EP | claimed |
| EP-0938496-A1 | HEPTAPEPTIDE OXYTOCIN ANALOGUES | FERRING B.V. (NL) | 1999-09-01 | — | — | EP | claimed |
| WO-1998023636-A1 | HEPTAPEPTIDE OXYTOCIN ANALOGUES | FERRING B.V. (NL) | 1998-06-04 | — | — | WO | claimed |
| US-4196204-A | ANTIANDROGENS, ACNE, SEBORRHEA | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | claimed |
| US-4112078-A | ACYLATION, REDUCTION, ZOAPATLE | ORTHO PHARMACEUTICAL CORPORATION (US) | 1978-09-05 | — | — | US | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | disclosed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | disclosed |
| US-12522647-B2 | Beta-arrestin mutants | PAUL SCHERRER INSTITUT (CH) | 2026-01-13 | — | — | US | disclosed |
| US-12479819-B2 | Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-4337311-A | 15 Hydroxylation of 1α,2α-methylene steroids | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | disclosed |
| US-4327039-A | Process for the production of 3-amino-1-hydroxypropane-1,1-diphosphonic acid | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1982-04-27 | — | — | US | disclosed |
| EP-0027982-A1 | Process for preparing 3-amino-1-hydroxypropane-1,1-diphosphonic acid | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-05-06 | — | — | EP | disclosed |
| US-4196204-A | ANTIANDROGENS, ACNE, SEBORRHEA | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | disclosed |
| US-4054598-A | SEQUESTERING AGENTS | HENKEL & CIE GMBH (DT) | 1977-10-18 | — | — | US | disclosed |
| US-3954845-A | Synthetic detergents of the ampholytic betaine type, process for preparing the same and compositions | MODOKEMI AKTIEBOLAG (SW) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | HTR2A 2841/4885HRH1 1574/4885PGR 4751/4885 |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | HTR2A 2669/4885HRH1 1996/4885PGR 3289/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | HTR2A 4372/4885HRH1 546/4885PGR 4381/4885 |
| US-12479819-B2 | Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities | HCRTR2, HCRTR1, MCHR2 | HTR2A 154/4885HRH1 106/4885PGR 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.